PRO FOOTBALL HALL OF FAMERS TOUCHDOWN TO EXPERIENCE JERUSALEM’S INNOVATION ALL-STARS Ronen Gadot, CEO of ElMindA and Robert Kraft, New England Patriots chairman and CEO
ElMindA Ltd. is delighted to announce the appointment of Dr. Arun Menawat as the new Chairman of its Board. Dr. Arun Menawat, has an accomplished history of executive leadership success in the healthcare industry. He served as the President & …
This week, Prime Minister Benjamin Netanyahu visited China and was accompanied by a senior business delegation of dozens of Israeli businesspeople from the various industries and companies active in China, as well as from companies interested in penetrating the Chinese …
ElMindA, a World Economic Forum technology pioneer, and EMOTIV, run by Tan Le, a World Economic Forum Young Global Leader, are among the companies working to make it happen. Read more on World Economic Forum.
Read more on Business Wire and Yahoo
Link to video: Personal Journeys with Brain Injury: Briana Scurry
Head of R&D, Dr. Amit Reches, discusses BNA with ElMundo (in Spanish)
Link to Press Release: ElMindA to Present at the Eleventh World Congress on Brain Injury: BNA™ As a Physiological Marker for Sports-Related Concussion
The research presented will examine a novel approach utilizing BNA to assess sports concussion through electrophysiological network activity which underlies brain function and dysfunction.
Link to video: USA Today
NFL Hall of Fame running back, Curtis Martin, discusses new brain health technologies at Super Bowl 50.
BNA™ (Brain Network Activation) provides detailed knowledge of brain function over time. Potential to impact an estimated 2 billion people worldwide living with neurological, psychiatric disorders. CHICAGO, November 16, 2015 – ElMindA Ltd., a pioneer in neuroscience-based technology for analyzing …
In honor of the famous neurologist’s life, GEEKTIME has compiled a list of five of the most innovative brain tech companies and projects operating today. read more.
The World Science Conference in Israel (WSCI) is a first of its kind gathering of academics and promising young talent from over 70 different countries including 15 Nobel laureates, Wolf Prize and Fields Medal winners, as well as over 400 science students. …
ElMindA has been honored among a select group of global innovators named to the World Economic Forum’s Technology Pioneers for 2015. The World Economic Forum’s Technology Pioneers program recognizes companies from around the world that are involved in the design, …
The 2015 American Academy of Neurology Sports Concussion Conference will take place July 24 through the 26 at the Colorado Convention Center in Denver, CO. The three day event will offer a one-of-a-kind opportunity for medical professionals to discover and …
A study published by Brain Imaging and Behavior provides important new information about the assessment of patients following a concussion, particularly those with post-traumatic migraine (PTM). The study compared individuals with PTM following sport-related concussion (SRC) to those without PTM …
Robert Kraft, New England Patriots Chairman and CEO, and 19 members of the U.S. Pro Football Hall of Fame learned firsthand about BNA during their recent trip to Israel in June 2015. Read more at The Times of Israel.
Athletico, a leader in head injury and concussion management, announced the availability of BNA™ testing at its Chicago-area facilities. Learn more here and review the article on the Daily Herald.
Herzliya – ElMindA Ltd. announced today that the Israeli Ministry of Health has approved registration of the company’s BNA™ Analysis System as a medical device for the assessment of brain function. Brain Network Activity (BNA™) combines non-invasive, multi-channel EEG technology with sophisticated signal processing and …
ElMindA, creator of the ground-breaking Brain Network Activation (BNA™) technology has been recognized once again for its innovative approach to neuroscience and management of brain disorders. The company was included on Fast Company’s annual list of the World’s Most Innovative …
BNATM technology and its potential utility in concussion assessment will be highlighted this week at the annual Big Sky Athletic Training and Sports Medicine Conference. Dr. Jeffrey Kutcher (University of Michigan) and Mike Palm (ATC, Athletico) will be giving a …
LONDON (Alliance News) – Electrical Geodesics Inc on Thursday said it has signed a two-year deal with ElMindA to provide its GES 400 systems to the US-Israeli company’s Brain Network Activation platform. The BNA platform is an analysis system which …
Japanese Prime Minister, Shinzo Abe, led a delegation of top Japanese businessmen, representing the largest companies in Japan, through an Israeli innovation exhibition showcasing breakthrough Israeli technologies. ElMindA was one of only five companies selected to present to …
BNA™ FDA clearance in the news: MDBR Medical Device Business Review, August 5th, 2014 “ElMindA obtains FDA approval for BNA Analysis System” Globes, August 6th, 2014 “ElMindA receives FDA approval for brain-scanner” Times of Israel, August 13th, 2014 “What’s on …
ANN ARBOR, Michigan; “Concussion test that feels like ‘octopus giving your head a hug’ could greatly benefit NFL players, other athletes”. Read the full story on BNATM
Advanced brain analysis and mapping technology enables assessment of brain health based on objective neurophysiological measures CHICAGO, Aug. 4, 2014 – ElMindA Ltd. announced today that the United States Food and Drug Administration (FDA) has cleared the company’s BNA™ Analysis …
Watch the Télématin FR2 story on BNA™ broadcast on June 17th 2014.
ElMindA has received a certification for EN ISO 13485:2012 and CMDCAS ISO 13485:2003, an international standard for a company-wide quality management system. EN ISO 13485:2012 certificate (Valid to March 2017) ISO 13485:2003 under CMDCAS certificate (Valid to March 2017)
Pittsburgh March 12th 2014 UPMC, Israeli company partner on brain-mapping work. A collaboration between the Israeli company ElMindA, and the UPMC Sports Medicine Concussion Program, has generated research results that could lead to better concussion assessments and more effective treatments. …
ElMindA has been chosen to showcase at The 2014 AIPAC conference in front of 14,000 people, taking place March 2nd-3rd 2014. Read more on JNS report and in Israel21c. Watch the innovation showcase presentation of CEO Ronen Gadot at AIPAC conference.
MINNEAPOLIS (WCCO) — This fall, 150 Minnesota youth hockey players are taking part in a study that’s using BNATM, a new concussion test to measure brainwaves. The studies’ directors believe the test could someday give parents an immediate diagnosis and peace …
Personalized Medicine World Conference (PMWC) International 2013, launched by Silicon Valley investors and entrepreneurs in 2009, provides a platform to foster collaboration, catalyze change and drive innovation in Personalized Medicine. At this year’s conference, Eighteen emerging companies defining the next …
Recent results of the BNA technology in concussion management were presented by Prof. Anthony P. Kontos (University of Pittsburgh, UPMC Sports Concussion Program) as part of his presentation on “The Cutting Edge of Concussion Research: From the Lab to the …
“Facing Tomorrow” – the fifth Israeli Presidential Conference under the auspices of President Shimon Peres – took place in Jerusalem on 18-20 June, 2013. As in previous years, the conference assembled world leaders, scholars, scientists, economists and business people to envision …
The finalists will present in front of an international judging committee at BrainTech Israel 2013, Israel’s first brain technology conference, which will take place on October 14-15, 2013 in Tel Aviv. For IBT official announcement click here.
ElMindA has been chosen to present at The Israeli Presidential Conference, Facing Tomorrow 2013, in a special brain exhibition: “Tomorrow state of Mind”, taking place June 18th-20th 2013. The Presidential Conference will assemble world leaders, international scholars, activists, poets and …
One month after announcing plans for a landmark effort to better understand the workings of the brain, President Obama received a first-hand look at a groundbreaking brain mapping and imaging technology that may be critical to achieving this ambitious …
The poster: “Applying Brain Network Activation (BNA) Analysis to Sport-related Concussion: Preliminary Report” presented at the 2013 Big Sky Athletic Training Sports Medicine Conference.
ElMindA and Purdue Pharma L.P. Enter Research Agreement to Develop Novel Diagnostics to Improve Pain Management Collaboration Extends Use of ElMindA BNA™ Technology Research Herzliya, Israel and Stamford, Conn. USA – January 29, 2013 – ElMindA – the developer …
ElMindA poster: “A Novel Brain Imaging Technology for Concussion Management Demonstrated on Simulated and Drug induced Impairmant” presented at the Penn State Concussion In Sports Conference.
View our poster at the exhibition, ALKS 5461: “A Novel Opioid Receptor Modulator, Normalizes Human EEG Responses in an Auditory Oddball Task after Cocaine Administration as Indicated by Brain Network Activation Analysis”
ElMindA poster: “A novel brain imaging technology for concussion management demonstrated on a scopolamine induced cognitive impairment model” presented at the 4th International Consensus Conference on Concussion in Sport
View our poster at the exhibit on Monday, October 15, 2012, from 1:00 PM to 5:00 PM
Keren Ziv to present in the 2012 ASCPT meeting http://www.ascpt.org/Meetings/tabid/6416/Default.aspx
The Wonders of our Mind Neuroscience Receiving a Transmission from the Brain ElMindA is developing a tool that measures our brain’s electrical fields and signals during brain activity, in order to enable brain-disorder diagnosis and treatment in real time …
Introducing a novel approach of network oriented analysis of ERPs, demonstrated on adult attention deficit hyperactivity disorder; G. Shahaf, A. Reches, N. Pinchuk, T. Fisher G. Ben Bashat, A. Kanter, I. Tauber, D. Kerem, I. Laufer, J. Aharon-Peretz, H. Pratt, …